Evolution of acute ischemic stroke therapy from lysis to thrombectomy: Similar or different to acute myocardial infarction?

International Journal of Cardiology

Volumn 222, Issue , 2016, Pages 441-447

  Elgendy, Islam Y ^a   Mahmoud, Ahmed N ^a   Mansoor, Hend ^b   Mojadidi, Mohammad K ^a   Bavry, Anthony A ^a,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ischemic; Myocardial infarction; Stroke; Thrombectomy; Thrombolysis

Indexed keywords

HEPARIN; PLACEBO; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ACUTE HEART INFARCTION; BARTHEL INDEX; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; EMBOLECTOMY SYSTEM; FIBRINOLYTIC THERAPY; FUNCTIONAL STATUS; GLASGOW OUTCOME SCALE; HUMAN; INTRACORONARY DRUG ADMINISTRATION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS THROMBECTOMY; PRIORITY JOURNAL; RANKIN SCALE; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT RETRIEVER; THROMBECTOMY; THROMBECTOMY DEVICE; THROMBUS ASPIRATION; COMPARATIVE STUDY; INTRAVENOUS DRUG ADMINISTRATION; MYOCARDIAL INFARCTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STROKE; TRENDS;

BRAIN ISCHEMIA; HUMANS; INFUSIONS, INTRAVENOUS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; THROMBECTOMY; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84982836732     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.07.251     Document Type: Review

References (53)

1. Lozano, R., Naghavi, M., Foreman, K., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 380 (2012), 2095–2128.
2. Rothwell, P.M., Coull, A.J., Silver, L.E., et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet. 366 (2005), 1773–1783.
3. Mozaffarian, D., Benjamin, E.J., Go, A.S., et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 133 (2016), 447–454.
4. Adams, H.P. Jr., Bendixen, B.H., Kappelle, L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke. 24 (1993), 35–41.
5. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet. 2 (1988), 349–360.
6. Simes, R.J., Topol, E.J., Holmes, D.R. Jr., et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. Circulation. 91 (1995), 1923–1928.
7. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333 (1995), 1581–1587.
8. van Swieten, J.C., Koudstaal, P.J., Visser, M.C., Schouten, H.J., van Gijn, J., Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 19 (1988), 604–607.
9. Kwiatkowski, T.G., Libman, R.B., Frankel, M., et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N. Engl. J. Med. 340 (1999), 1781–1787.
10. Hacke, W., Kaste, M., Fieschi, C., et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 274 (1995), 1017–1025.
11. Hacke, W., Kaste, M., Fieschi, C., et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 352 (1998), 1245–1251.
12. Clark, W.M., Wissman, S., Albers, G.W., Jhamandas, J.H., Madden, K.P., Hamilton, S., Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study: a randomized controlled trial. JAMA. 282 (1999), 2019–2026.
13. Hacke, W., Kaste, M., Bluhmki, E., et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359 (2008), 1317–1329.
14. Higashida, R.T., Furlan, A.J., Roberts, H., et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 34 (2003), e109–e137.
15. Bhatia, R., Hill, M.D., Shobha, N., et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke. 41 (2010), 2254–2258.
16. Chazov, E.I., Matveeva, L.S., Mazaev, A.V., Sargin, K.E., Sadovskaia, G.V., Ruda, M.I., Intracoronary administration of fibrinolys in acute myocardial infarct. Ter. Arkh. 48 (1976), 8–19.
17. Kennedy, J.W., Ritchie, J.L., Davis, K.B., Fritz, J.K., Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N. Engl. J. Med. 309 (1983), 1477–1482.
18. Patel, B., Kloner, R.A., Analysis of reported randomized trials of streptokinase therapy for acute myocardial infarction in the 1980s. Am. J. Cardiol. 59 (1987), 501–504.
19. Zeumer, H., Hacke, W., Ringelstein, E.B., Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. AJNR Am. J. Neuroradiol. 4 (1983), 401–404.
20. Furlan, A., Higashida, R., Wechsler, L., et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. JAMA. 282 (1999), 2003–2011.
21. Simoons, M.L., Arnold, A.E., Betriu, A., et al. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet. 1 (1988), 197–203.
22. Gibbons, R.J., Holmes, D.R., Reeder, G.S., Bailey, K.R., Hopfenspirger, M.R., Gersh, B.J., Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N. Engl. J. Med. 328 (1993), 685–691.
23. Grines, C.L., Browne, K.F., Marco, J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N. Engl. J. Med. 328 (1993), 673–679.
24. Zijlstra, F., de Boer, M.J., Hoorntje, J.C., Reiffers, S., Reiber, J.H., Suryapranata, H., A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N. Engl. J. Med. 328 (1993), 680–684.
25. Keeley, E.C., Boura, J.A., Grines, C.L., Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 361 (2003), 13–20.
26. Cannon, C.P., Gibson, C.M., Lambrew, C.T., et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 283 (2000), 2941–2947.
27. De Luca, G., Suryapranata, H., Ottervanger, J.P., Antman, E.M., Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts. Circulation. 109 (2004), 1223–1225.
28. Kidwell, C.S., Jahan, R., Gornbein, J., et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N. Engl. J. Med. 368 (2013), 914–923.
29. Broderick, J.P., Palesch, Y.Y., Demchuk, A.M., et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N. Engl. J. Med. 368 (2013), 893–903.
30. Ciccone, A., Valvassori, L., Nichelatti, M., et al. Endovascular treatment for acute ischemic stroke. N. Engl. J. Med. 368 (2013), 904–913.
31. Chimowitz, M.I., Endovascular treatment for acute ischemic stroke-still unproven. N. Engl. J. Med. 368 (2013), 952–955.
32. Nogueira, R.G., Lutsep, H.L., Gupta, R., et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 380 (2012), 1231–1240.
33. Saver, J.L., Jahan, R., Levy, E.I., et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 380 (2012), 1241–1249.
34. Berkhemer, O.A., Fransen, P.S., Beumer, D., et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N. Engl. J. Med. 372 (2015), 11–20.
35. Campbell, B.C., Mitchell, P.J., Kleinig, T.J., et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N. Engl. J. Med. 372 (2015), 1009–1018.
36. Goyal, M., Demchuk, A.M., Menon, B.K., et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N. Engl. J. Med. 372 (2015), 1019–1030.
37. Saver, J.L., Goyal, M., Bonafe, A., et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N. Engl. J. Med. 372 (2015), 2285–2295.
38. Jovin, T.G., Chamorro, A., Cobo, E., et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N. Engl. J. Med. 372 (2015), 2296–2306.
39. Elgendy, I.Y., Bhatt, D.L., Bavry, A.A., Mechanical thrombectomy and functional outcomes after stroke. JAMA., 315, 2016, 1791.
40. Powers, W.J., Derdeyn, C.P., Biller, J., et al. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 46 (2015), 3020–3035.
41. Elgendy, I.Y., Kumbhani, D.J., Mahmoud, A., Bhatt, D.L., Bavry, A.A., Mechanical thrombectomy for acute ischemic stroke: a meta-analysis of randomized trials. J. Am. Coll. Cardiol. 66 (2015), 2498–2505.
42. Goyal, M., Menon, B.K., van Zwam, W.H., et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 387 (2016), 1723–1731.
43. Mahmoud, A.N., Elgendy, I.Y., Bavry, A.A., Current considerations of thrombectomy for acute myocardial infarction. Cardiovascular Innovations and Applications. 1 (2016), 265–272.
44. Bavry, A.A., Kumbhani, D.J., Bhatt, D.L., Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials. Eur. Heart J. 29 (2008), 2989–3001.
45. Elgendy, I.Y., Huo, T., Bhatt, D.L., Bavry, A.A., Is aspiration thrombectomy beneficial in patients undergoing primary percutaneous coronary intervention? Meta-analysis of randomized trials. Circ. Cardiovasc. Interv., 8, 2015, e002258.
46. Mahmoud, A.N., Bavry, A.A., Elgendy, I.Y., The risk for stroke with aspiration thrombectomy: procedure or patient related? Insights from a meta-analysis. JACC Cardiovasc. Interv., 2016, 10.1016/j.jcin.2016.06.011 (Epub ahead of print).
47. Elgendy, I.Y., Wen, X., Mahmoud, A., Bavry, A.A., Complete versus culprit-only revascularization for patients with multi-vessel disease undergoing primary percutaneous coronary intervention: an updated meta-analysis of randomized trials. Catheter. Cardiovasc. Interv., 2015, 10.1002/ccd.26322 (Epub ahead of print).
48. Elgendy, I.Y., Wen, X., Mahmoud, A., Bavry, A.A., Complete versus culprit-only revascularization in patients with multi-vessel disease undergoing primary percutaneous coronary intervention: a meta-analysis of randomized trials. Int. J. Cardiol. 186 (2015), 98–103.
49. Menon, B.K., Saver, J.L., Goyal, M., et al. Trends in endovascular therapy and clinical outcomes within the nationwide get with the guidelines-stroke registry. Stroke 46 (2015), 989–995.
50. Widimsky, P., Coram, R., Abou-Chebl, A., Reperfusion therapy of acute ischaemic stroke and acute myocardial infarction: similarities and differences. Eur. Heart J. 35 (2014), 147–155.
51. Htyte, N., Parto, P., Ragbir, S., Jaffe, L., White, C.J., Predictors of outcomes following catheter-based therapy for acute stroke. Catheter. Cardiovasc. Interv. 85 (2015), 1043–1050.
52. Goyal, M., Jadhav, A.P., Bonafe, A., et al. Analysis of workflow and time to treatment and the effects on outcome in endovascular treatment of acute ischemic stroke: results from the SWIFT PRIME randomized controlled trial. Radiology., 160204, 2016 (Epub ahead of print).
53. Ribo, M., Molina, C.A., Cobo, E., et al. Association between time to reperfusion and outcome is primarily driven by the time from imaging to reperfusion. Stroke. 47 (2016), 999–1004.